Login to Your Account



Probiodrug Acquires Ingenium For Stock, Raises $27.7M In Cash

By Cormac Sheridan


Wednesday, June 27, 2007
Probiodrug AG has acquired fellow German firm Ingenium Pharmaceuticals AG in a stock-based deal and has closed a €20.6 million (US$27.7 million) venture capital round at the same time, to fund both an in-house drug development program in Alzheimer's disease and a newly acquired program in inflammation. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription